New Study Sponsored by Cognoa Exposes Alarming Wait Times and Persistent Inequities Obstructing Early Autism Diagnosis and Early Interventions
November 8, 2023
Fierce Names Dr. Dennis Wall, Founder of Cognoa, as One of its Fierce 50 Honorees of 2023
October 3, 2023
Cognoa and Health Transformation Alliance Partner to Provide Access to Child Health Solution Canvas Dx for Self-Insured Employers
February 16, 2023
Cognoa Appoints Pediatric Neurologist and AI in Healthcare Pioneer Dr. Sharief Taraman as CEO to Spearhead the Next Stage of the Company’s Growth
November 14, 2022
Cognoa Announces Poster Presentations at the 2022 American Academy of Pediatrics (AAP) National Conference and Exhibition
October 7, 2022
ECHO Autism Communities Collaborate with Cognoa to Study Real-World Application of Canvas Dx
June 1, 2022
Cognoa Announces Nature Digital Medicine Publication of Pivotal Study Results Showing the Effectiveness of its Digital Diagnostic Device for Autism
May 5, 2022
Cognoa to Present and Exhibit at the 2022 American Academy of Neurology (AAN) Annual Meeting
April 4, 2022
Cognoa Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer
September 30, 2021